BioNTech SE Net Asset Quality Index
BioNTech SE net asset quality index. BioNTech SE (22UA) has a Net Asset Quality Index of 88.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €21.07 Billion minus total liabilities of €2.38 Billion yields net assets of €18.70 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check BioNTech SE cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of BioNTech SE (2016–2025)
Net asset quality index of BioNTech SE from 2016 to 2025. This chart shows how BioNTech SE's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the index stands at 88.7%, representing net assets of €18.70 Billion against total assets of €21.07 Billion EUR. See 22UA total equity for net asset value and shareholders' equity analysis.
BioNTech SE Net Asset Quality Index by Year (2016–2025)
BioNTech SE net asset quality index by year from 2016 to 2025. The table below presents the year-by-year Net Asset Quality Index for BioNTech SE from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 22UA market cap.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.4% | €19.22 Billion | €21.99 Billion | €2.76 Billion | ▲ +1.3 pp |
| 2024 | 86.2% | €19.41 Billion | €22.53 Billion | €3.12 Billion | ▼ -1.8 pp |
| 2023 | 88.0% | €20.25 Billion | €23.01 Billion | €2.76 Billion | ▲ +1.8 pp |
| 2022 | 86.2% | €20.06 Billion | €23.28 Billion | €3.22 Billion | ▲ +11.0 pp |
| 2021 | 75.1% | €11.89 Billion | €15.83 Billion | €3.94 Billion | ▲ +16.0 pp |
| 2020 | 59.2% | €1.37 Billion | €2.32 Billion | €946.77 Million | ▼ -2.7 pp |
| 2019 | 61.9% | €493.49 Million | €797.65 Million | €304.15 Million | ▲ +21.0 pp |
| 2018 | 40.9% | €267.00 Million | €652.99 Million | €385.99 Million | ▲ +53.8 pp |
| 2017 | -12.9% | €-48.21 Million | €374.71 Million | €422.92 Million | ▼ -21.0 pp |
| 2016 | 8.2% | €31.86 Million | €389.96 Million | €358.10 Million | — |